News

Bugworks Research starts first human dose study to treat critical bacterial infections

Bugworks Research starts first human dose study to treat critical bacterial infectionsBengaluru : Bugworks Research announced that the first human dose was administered in a phase 1 clinical trial evaluating BWC0977: a next generation broad-spectrum, novel bacterial topoisomerase inhibitor (NBTI), supported by Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X).

Feb 07, 2022

By : ABLE

String Bio shows the way to convert methane into biostimulants for crops, animal feed

String Bio products made through fermentation helps reduce the release of greenhouse gas.

Feb 07, 2022

By : ABLE

DoP releases draft policy to catalyse R&D and innovation in pharma-MedTech sector

The draft policy aims to encourage R&D in Pharma-MedTech sector, and promoting innovation for India to become a leader in drug discovery and innovative medical devices through incubating an entrepreneurial environment. The department has invited comments from the stakeholders by November 6, 2021.

Oct 29, 2021

By : Pharmabiz

Union Minister of Health and Family Welfare, GoI, launches first commercial batch of COVAXIN® manufactured in Ankleshwar, Gujarat

Bharat Biotech, a global leader in vaccine development and innovation, today announced the commercial launch of the first batch of COVAXIN® from its Chiron Behring Vaccines facility in Ankleshwar, Gujarat. Hon’ble Union Health Minister of Health and Family Welfare Shri. Mansukh Mandaviya inaugurated the COVAXIN® batches.

Aug 29, 2021

By : Team ABLE

IVI and Bharat Biotech launch Global Chikungunya Vaccine Phase II/III trial in Costa Rica

IVI is leading the Global Chikungunya vaccine Clinical Development Program (GCCDP) consortium in partnership with Bharat Biotech and with support from      the Coalition for Epidemic Preparedness Innovations (CEPI) and Ind-CEPI.

Aug 25, 2021

By : Team ABLE

 

Archives